ALCAM and asthma: Given that ALCAM−/− mice display reduced T cell activation and T cell mediated inflammatory responses in experimental mouse models of antigen-induced food allergy or asthma (10, 11), it is possible that the I/F8-mediated delay in corneal allograft rejection can in part be attributed to direct effects on T cell activation.